Literature DB >> 12406655

Efficacy of DNA vaccination by different routes of immunisation in sheep.

Robert De Rose1, Jan Tennent, Peter McWaters, Paul J Chaplin, Paul R Wood, Wayne Kimpton, Ross Cahill, Jean Pierre Y Scheerlinck.   

Abstract

DNA vaccination, delivered through various routes, has been used extensively in laboratory animals. Few studies have focused on veterinary species and while results obtained in laboratory animals can often be extrapolated to veterinary species this is not always the case. In this study we have compared the effect of the route of immunisation with DNA on the induction of immune responses and protection of sheep to challenge with live Corynebacterium pseudotuberculosis. Intramuscular injection of plasmid DNA encoding an inactivated form of the phospholipase D (PLD) antigen linked to CTLA4-Ig resulted in the induction of a strong memory response and sterile immunity following challenge in 45% of the animals. In contrast, gene gun delivery or subcutaneous (SC) injection of the DNA vaccine induced comparatively poor responses and insignificant levels of protection. Thus, DNA vaccine efficacy in sheep is strongly influenced by the route of vaccination. Amongst intramuscular vaccinates, protected sheep had significantly elevated IgG2 responses compared to unprotected animals, while both subgroups had equivalent IgG1 levels. This suggests that the presence of IgG2 antibodies and hence a Th1-like response, induced by the DNA vaccine gave rise to protective immunity against C. pseudotuberculosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406655     DOI: 10.1016/s0165-2427(02)00221-0

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  Immune-Informatic Analysis and Design of Peptide Vaccine From Multi-epitopes Against Corynebacterium pseudotuberculosis.

Authors:  Daniela Droppa-Almeida; Elton Franceschi; Francine Ferreira Padilha
Journal:  Bioinform Biol Insights       Date:  2018-05-14

2.  Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.

Authors:  Donna Mahony; Karishma T Mody; Antonino S Cavallaro; Qiuhong Hu; Timothy J Mahony; Shizhang Qiao; Neena Mitter
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

3.  An iron-acquisition-deficient mutant of Corynebacterium pseudotuberculosis efficiently protects mice against challenge.

Authors:  Dayana Ribeiro; Flávia de Souza Rocha; Kátia Morais Costa Leite; Siomar de Castro Soares; Artur Silva; Ricardo Wagner Dias Portela; Roberto Meyer; Anderson Miyoshi; Sérgio Costa Oliveira; Vasco Azevedo; Fernanda Alves Dorella
Journal:  Vet Res       Date:  2014-03-06       Impact factor: 3.683

4.  Induction of IFN-γ cytokine response against hepatitis B surface antigen using melittin.

Authors:  Hoda Taghizadeh Dezfuli; Delavar Shahbazzadeh; Akram Eidi; Kamran Pooshang Bagheri; Nafiseh Pakravan; Safie Amini; Mohammad Reza Aghasadeghi; Mehdi Mahdavi
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

Review 5.  Insight of Genus Corynebacterium: Ascertaining the Role of Pathogenic and Non-pathogenic Species.

Authors:  Alberto Oliveira; Leticia C Oliveira; Flavia Aburjaile; Leandro Benevides; Sandeep Tiwari; Syed B Jamal; Arthur Silva; Henrique C P Figueiredo; Preetam Ghosh; Ricardo W Portela; Vasco A De Carvalho Azevedo; Alice R Wattam
Journal:  Front Microbiol       Date:  2017-10-12       Impact factor: 5.640

6.  Leader gene of Corynebacterium pseudotuberculosis may be useful in vaccines against caseous lymphadenitis of goats: a bioinformatics approach.

Authors:  Eliane Macedo Sobrinho Santos; Anna Christina Almeida; Hércules Otacílio Santos; Alex Sander Rodrigues Cangussu; Deborah Aires Almeida; Kattyanne Souza Costa
Journal:  J Vet Med Sci       Date:  2018-06-25       Impact factor: 1.267

7.  Comparative analysis of the immunogenicity of SARS-CoV nucleocapsid DNA vaccine administrated with different routes in mouse model.

Authors:  Hui Hu; Xianqing Huang; Ling Tao; Yi Huang; Bao-An Cui; Hanzhong Wang
Journal:  Vaccine       Date:  2009-01-30       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.